Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1535-1540
Published online before print July 3, 2003, doi: 10.1161/01.ATV.0000084639.16462.7A
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/9/1535    most recent
01.ATV.0000084639.16462.7Av1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arkenbout, E. K.
Right arrow Articles by de Vries, C. J.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arkenbout, E. K.
Right arrow Articles by de Vries, C. J.M.
Related Collections
Right arrow Health policy and outcome research
Right arrow Coagulation inhibitors
Right arrow Acute coronary syndromes
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1535.)
© 2003 American Heart Association, Inc.


Vascular Biology

TR3 Orphan Receptor Is Expressed in Vascular Endothelial Cells and Mediates Cell Cycle Arrest

E. Karin Arkenbout; Maaike van Bragt; Eric Eldering; Chris van Bree; Jos M. Grimbergen; Paul H.A. Quax; Hans Pannekoek; Carlie J.M. de Vries

From the Departments of Biochemistry (E.K.A., M.v.B., H.P., C.J.M.d.V.), Experimental Immunology (E.E.), and Radiotherapy (C.v.B.), Academic Medical Center, University of Amsterdam, Amsterdam, and the Gaubius Laboratory TNO-PG (J.M.G., P.H.A.Q.), Leiden, the Netherlands.

Correspondence to Carlie J.M. de Vries, PhD, Department of Biochemistry, Academic Medical Center, K1[hyphen]163, Meibergdreef 15 1105 AZ Amsterdam, The Netherlands. E-mail: c.j.devries{at}amc.uva.nl

Objective— Endothelial cells play a pivotal role in vascular homeostasis. In this study, we investigated the function of the nerve growth factor–induced protein-B (NGFI-B) subfamily of nuclear receptors comprising the TR3 orphan receptor (TR3), mitogen-induced nuclear orphan receptor (MINOR), and nuclear orphan receptor of T cells (NOT) in endothelial cells.

Methods and Results— The mRNA expression of TR3, MINOR, and NOT in atherosclerotic lesions was assessed in human vascular specimens. Each of these factors is expressed in smooth muscle cells, as described before, and in subsets of endothelial cells, implicating that they might affect endothelial cell function. Adenoviral overexpression of TR3 in cultured endothelial cells resulted in decreased [3H]thymidine incorporation, whereas a dominant-negative TR3 variant that inhibits the activity of endogenous TR3-like factors enhanced DNA synthesis. TR3 interfered with progression of the cell cycle by upregulating p27Kip1 and downregulating cyclin A, whereas expression levels of a number of other cell cycle–associated proteins remained unchanged.

Conclusions— These findings demonstrate that TR3 is a modulator of endothelial cell proliferation and arrests endothelial cells in the G1 phase of the cell cycle by influencing cell cycle protein levels. We hypothesize involvement of TR3 in the maintenance of integrity of the vascular endothelium.


Key Words: endothelial cells • TR3 orphan receptor • cell cycle • vascular biology




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
L. Martorell, M. Gentile, J. Rius, C. Rodriguez, J. Crespo, L. Badimon, and J. Martinez-Gonzalez
The Hypoxia-Inducible Factor 1/NOR-1 Axis Regulates the Survival Response of Endothelial Cells to Hypoxia
Mol. Cell. Biol., November 1, 2009; 29(21): 5828 - 5842.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. C. Evans
Nur77: Orphaned at Birth but Adopted by the Nuclear Factor {kappa}B Signaling Pathway
Circ. Res., March 27, 2009; 104(6): 707 - 709.
[Full Text] [PDF]


Home page
Circ. Res.Home page
B. You, Y.-Y. Jiang, S. Chen, G. Yan, and J. Sun
The Orphan Nuclear Receptor Nur77 Suppresses Endothelial Cell Activation Through Induction of I{kappa}B{alpha} Expression
Circ. Res., March 27, 2009; 104(6): 742 - 749.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. S. Mix, M. G. Attur, H. Al-Mussawir, S. B. Abramson, C. E. Brinckerhoff, and E. P. Murphy
Transcriptional Repression of Matrix Metalloproteinase Gene Expression by the Orphan Nuclear Receptor NURR1 in Cartilage
J. Biol. Chem., March 30, 2007; 282(13): 9492 - 9504.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Fumoto, T. Yamaguchi, F. Hirose, and T. Osumi
Orphan Nuclear Receptor Nur77 Accelerates the Initial Phase of Adipocyte Differentiation in 3T3-L1 Cells by Promoting Mitotic Clonal Expansion
J. Biochem., February 1, 2007; 141(2): 181 - 192.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. I. Bonta, C. M. van Tiel, M. Vos, T. W.H. Pols, J. V. van Thienen, V. Ferreira, E. K. Arkenbout, J. Seppen, C. A. Spek, T. van der Poll, et al.
Nuclear Receptors Nur77, Nurr1, and NOR-1 Expressed in Atherosclerotic Lesion Macrophages Reduce Lipid Loading and Inflammatory Responses
Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2288 - 2288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. de Waard, E. K. Arkenbout, M. Vos, A. I.M. Mocking, H. W.M. Niessen, W. Stooker, B. A.J.M. de Mol, P. H.A. Quax, E. N.T.P. Bakker, E. VanBavel, et al.
TR3 Nuclear Orphan Receptor Prevents Cyclic Stretch-Induced Proliferation of Venous Smooth Muscle Cells
Am. J. Pathol., June 1, 2006; 168(6): 2027 - 2035.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Ahamed, M. Belting, and W. Ruf
Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1
Blood, March 15, 2005; 105(6): 2384 - 2391.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Martinez-Gonzalez and L. Badimon
The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells
Cardiovasc Res, February 15, 2005; 65(3): 609 - 618.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. H. Bassett, T. Suzuki, H. Sasano, C. J. M. de Vries, P. T. Jimenez, B. R. Carr, and W. E. Rainey
The Orphan Nuclear Receptor NGFIB Regulates Transcription of 3{beta}-Hydroxysteroid Dehydrogenase: IMPLICATIONS FOR THE CONTROL OF ADRENAL FUNCTIONAL ZONATION
J. Biol. Chem., September 3, 2004; 279(36): 37622 - 37630.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Liu, H. Jia, D. I. R. Holmes, A. Stannard, and I. Zachary
Vascular Endothelial Growth Factor-Regulated Gene Expression in Endothelial Cells: KDR-Mediated Induction of Egr3 and the Related Nuclear Receptors Nur77, Nurr1, and Nor1
Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 2002 - 2007.
[Abstract] [Full Text] [PDF]